Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole for Bipolar Depression
NCT03427892Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Mar 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brexpiprazole in bipolar disorder (BD), sponsored by UT Southwestern Medical Center. Started Mar 2017; status: completed.
02
Drugs
brexpiprazole
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT03427892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03427892.